Literature DB >> 10647671

Nephrovesical subcutaneous stent: an alternative to permanent nephrostomy.

I Nissenkorn1, Y Gdor.   

Abstract

PURPOSE: We studied whether a subcutaneous ureteral bypass may be an alternative to a permanent nephrostomy tube in patients with ureteral obstruction caused by pelvic malignancy.
MATERIALS AND METHODS: Using local anesthesia we inserted an especially designed nephrovesical stent into subcutaneous tissue. The stent consists of 2 J stents that are joined by a connector after insertion into the renal pelvis and bladder.
RESULTS: In 8 patients 10 subcutaneous stents were inserted instead of a permanent nephrostomy tube. Nephrostomy was required because of obstructed ureters caused by metastatic prostate or invasive bladder cancer. Attempted Double-J stent insertion into the obstructed ureter had previously failed. The bypass has functioned well in all cases during 6 weeks to 18 months of followup (mean 5.5 months).
CONCLUSIONS: The high complication rate of a permanent nephrostomy tube and frequent rehospitalization render the subcutaneous stent an important alternative to nephrostomy. The subcutaneous stent eliminates external devices for urine drainage and improves patient quality of life.

Entities:  

Mesh:

Year:  2000        PMID: 10647671     DOI: 10.1016/s0022-5347(05)67917-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  [Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis].

Authors:  H Loertzer; A Jurczok; S Wagner; P Fornara
Journal:  Urologe A       Date:  2003-05-27       Impact factor: 0.639

2.  Long-term results of the treatment of complex ureteral stenosis with extra-anatomic ureteral bypasses.

Authors:  Inés M Laso-García; Javier Lorca-Álvaro; Fernando Arias-Fúnez; David Díaz-Pérez; Marta Santiago-González; Gemma Duque-Ruiz; Francisco J Burgos-Revilla
Journal:  Cent European J Urol       Date:  2020-06-19

3.  [Long-term results for subcutaneous Detour® prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications].

Authors:  A Janitzky; J Borski; M Porsch; J J Wendler; D Baumunk; U-B Liehr; M Schostak
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

4.  Subcutaneous nephrovesical bypass: Treatment for ureteral obstruction in advanced metastatic disease.

Authors:  Yunyan Wang; Gongcheng Wang; Peijin Hou; Haijun Zhuang; Xiaosong Yang; Shuo Gu; Hengbing Wang; Lu Ji; Zongyuan Xu; Junsong Meng
Journal:  Oncol Lett       Date:  2014-11-06       Impact factor: 2.967

5.  Use of a subcutaneous ureteral bypass device for treatment of bilateral proximal ureteral injury in a 9-month-old cat.

Authors:  Joseph A Sapora; Robert J Hardie; Natashia Evans
Journal:  JFMS Open Rep       Date:  2019-03-11

6.  Subcutaneous nephrovesical bypass in kidney transplanted patients.

Authors:  M Yazdani; M R Gharaati; M Zargham
Journal:  Int J Organ Transplant Med       Date:  2010
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.